Authors
Li WG.
Institution
Qidong Liver Cancer Institute, Jiangsu.
Title
[Preliminary observations on effect of selenium
yeast on high risk populations with primary liver cancer].
[Chinese]
Source
Chung-Hua Yu Fang i Hsueh Tsa Chih [Chinese Journal of Preventive Medicine].
26(5):268-71, 1992 Sep.
Abstract
Two populations with high risk primary liver cancer (PLC), one of 226 cases
with HBsAg carriers and another of 3849 first-relatives in the pedigree with
high incidence of PLC, were randomly divided into the supplementing
selenium group (selenium
yeast 200 g Se1Tab/day) and the control group (common
yeast 1 Tab/day), and were followed-up for four years and
two years respectively. In the population with HBsAg carriers, no liver
cancer occurred in the supplementing selenium group; where
as the liver cancer incidence rate was 1573.03/10(5) in the control group.
Among the first relatives. The liver cancer incidence rate in the
supplementing selenium group was 219.37/10(5); and
553.15/10(5) in the control group. The results showed that the incidence of
PLC in the supplementing selenium group was significantly
lower than in the control group. This study indicates that
selenium has distinct anti-PLC effect.